Industry – Page 28 – Swanson Reed | Specialist R&D Tax Advisors

ANI Pharmaceuticals Completes Acquisition of Novitium Pharma

ANI Pharmaceuticals, Inc. has successfully completed the acquisition of Novitium Pharma, a New-Jersey-based pharmaceutical company.

Based in Baudette, Minnesota, ANI Pharmaceuticals is an integrated specialty pharmaceutical company developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals.

With the combined forces of Novitium and ANI Pharmaceuticals, the company is looking forward to expanded R&D capabilities. The acquisition brings aboard a world-class R&D engine in the generic and 505(b)(2) sectors as well as a highly-compliant US based manufacturing facility. With these additions, they are well positioned for sustainable growth.

“ANI is thrilled to welcome the expertise and leadership of Novitium’s founders, Samy Shanmugam, Chad Gassert and Vijay Thorappadi, along with over 100 talented and dedicated employees, who have joined the ANI team. Our robust product pipeline includes several more CGT and 505 (b)(2) candidates and will be further expanded to maximize the value of our bolstered R&D engine,” said Nikhil Lalwani, President and Chief Executive Officer of ANI.

Are you developing new pharmaceuticals for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Rove Expands Cannabis Products into Massachusetts

Rove, a legacy cannabis manufacturer, has launched its award-winning cannabis products to dispensaries across Massachusetts. This product line includes six black box vape SKUs and another 7 will be launched this winter. The following year will see the launch of live resin, infused pre-rolls and other award-winning products into the state. They have also partnered with Cloud Creamery to facilitate this Massachusetts market-entry.

Rove has been committed to developing best-in-class cannabis products. To ensure customers have a full understanding of the products they are using, each product has a QR code which details terpene content and guarantees authenticity. This prevents the chance of fraudulent products making the rounds.

In order to achieve these best-in-class results, Rove has committed to formulating each product in house through their extensive R&D processes. Their Massachusetts products are handmade locally by Massachusetts residents and formulated with absolutely zero fillers.

While new to Massachusetts, Rove originally launched in California and has become the number-one-selling vape brand in Nevada. It is seeing exponential growth in new markets Michigan, Oklahoma and Arizona. In addition to vapes, Rove produces flower, pre-rolls, concentrates and hemp CBD products.

Are you developing new formulas for existing products? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Tonix Pharmaceuticals Moves TNX-1900 into Phase 2 Studies After FDA Clearance

Sartorius AG to Open Center of Excellence in Michigan

Tonix Pharmaceuticals Holding Corp. has announced the successful FDA clearance of their investigational new drug (IND) for Potentiated Intranasal Oxytocin (TNX-1900). The treatment can be used to prevent migraine headaches for those chronically afflicted.

Tonix is a clinical-stage biopharmaceutical company based in New Jersey who has spent their time repurposing drugs for central nervous system conditions.

The FDA clearance will allow TNX-1900 to be pushed into a Phase 2 study. The study is expected to qualify for the 505(b)(2) pathway for full FDA approval – a pathway available only to new formulations of an approved drug.

Migraines are a symptom of a neurological condition which manifests in throbbing headaches, light auras, and aversions to lights, smells, and noises. Tonix believes that by engaging and stimulating oxytocin receptors in the trigeminal ganglia, TNX-1900 could prevent migraines. The drug contains magnesium which potentiates the action of oxytocin at oxytocin receptors in animal models.

Oxytocin is a naturally occurring human hormone with no recognized addiction potential. It has been observed that lowered oxytocin levels in the body can lead to increased migraine headache frequency. Some other chronic pain conditions are also associated with low oxytocin levels.

Tonix has further plans to develop TNX-1900 for craniofacial pain and insulin resistance.

Are you developing new pharmaceuticals for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

MDI Biological Laboratory Discovers Protection of Muscle During Dietary Restriction

MDI Biological Laboratory, a Maine-based biomedical research institution, has discovered that muscle may be a protected tissue under dietary restriction conditions.

Dietary restriction has been a robust anti-aging intervention tool for a while now. This process has the patient restrict calories without reaching malnutrition. In face of the scarce nutrients, the organism conserves resources by lowering the translation of proteins. Protein translation is one of the most energetically costly processes in a cell.

By conserving these cellular resources, the organism can reproduce when food becomes available but comes at the cost of reduced anabolic function, growth, and reproduction.

Aric N. Rogers, PH.D. at MDI Biological Labs has studied the cellular and molecular mechanisms of aging. Rogers has worked with tiny nematode worms, C. elegans, to evaluate the impact of suppressed protein translation. Skin, nerve, and reproductive tissues responded as expected with enhanced survival and decreased growth and reproduction, muscle experienced the opposite effect.

Muscle tissue experienced accelerated growth and reproduction instead of suppression.

elegans is a popular model in aging research because it shares many of its genes with humans, including those governing nutrient-sensing pathways, and because its short lifespan allows scientists to rapidly assess the effects of anti-aging interventions.

This discovery could contribute to the development of anti-aging drugs without side effects.

Are you developing new software for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

MDI Biological Laboratory Discovers Protection of Muscle During Dietary Restriction

MDI Biological Laboratory, a Maine-based biomedical research institution, has discovered that muscle may be a protected tissue under dietary restriction conditions.

Dietary restriction has been a robust anti-aging intervention tool for a while now. This process has the patient restrict calories without reaching malnutrition. In face of the scarce nutrients, the organism conserves resources by lowering the translation of proteins. Protein translation is one of the most energetically costly processes in a cell.

By conserving these cellular resources, the organism can reproduce when food becomes available but comes at the cost of reduced anabolic function, growth, and reproduction.

Aric N. Rogers, PH.D. at MDI Biological Labs has studied the cellular and molecular mechanisms of aging. Rogers has worked with tiny nematode worms, C. elegans, to evaluate the impact of suppressed protein translation. Skin, nerve, and reproductive tissues responded as expected with enhanced survival and decreased growth and reproduction, muscle experienced the opposite effect.

Muscle tissue experienced accelerated growth and reproduction instead of suppression.

elegans is a popular model in aging research because it shares many of its genes with humans, including those governing nutrient-sensing pathways, and because its short lifespan allows scientists to rapidly assess the effects of anti-aging interventions.

This discovery could contribute to the development of anti-aging drugs without side effects.

Are you developing new software for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Skretting and Atlantic Sapphire Announce Partnership to Develop Zero Marine Ingredient Salmon Diet

Skretting, a Vancouver-based feed manufacturing company, has announced an agreement with Atlantic Sapphire to build a state of the art RAS feed facility in Florida.

This feed facility will serve Atlantic Sapphire’s recirculation system (RAS) operations. Skretting will build and finance the feed plant while Atlantic Sapphire will source the majority of its salmon feed demand. The contract has a 10 year life span, wherein Atlantic Sapphire will continue to source the salmon the entire decade.

This local feed source will reduce production costs and GHG emissions significantly.

Skretting has a stellar history of R&D, influencing Atlantic Sapphire’s decision in partnering up with them. This R&D record is set to continue as the two companies commit to developing specialist RAS salmon diets while reducing carbon footprints. This requires the testing and integration of novel ingredients and formulas. The ultimate goal is to use zero marine ingredients in the salmon diet without reducing the required levels of omega-3 fatty acids in the final product.

Are you developing new processes or formulas for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Nepra Prepares to Bring Textured Hemp Protein to the Plant-Based Protein Market

Nepra Foods, Ltd., a Colorado-based vegan food company, has recently announced the expansion of their facility with the installation of proprietary THP™ production equipment.

The company has focused on the formulation, development, and production of plant-based and allergen-free food. With the addition of this new equipment, they are better equipped to produce their proprietary THP (textured hemp protein) – the basis of their PROPASTA™ product line. PROPASTA is a line of ready-to-eat frozen meals and meat analogues.

This step towards self-sufficient production processes should help the company combat shipping lead times which are at an all-time high due to the global supply chain disruptions. It will provide the tools needed for large-scale production processes as Nepra Foods aims to scale up their processes in preparation for their PROPASTA™ product launch in early 2022. This will require the continuation of in-house testing and accelerated product innovation leading to national distribution.

Nepra Foods is committed to developing plant-based foods that provide the necessary nutrition without compromising quality or taste. They take this mission one step further by formulating food that is allergen-free.

Are you developing new formulas for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

AIM Photonics Secures New 7 Year Agreement

Arkansas Patent of the Month - September 2021

New York-based AIM Photonics (American Institute of Manufacturing Photonics) has secured a new seven-year cooperative agreement with the Air Force Research Laboratory (AFRL) and the Research Foundation of the State University of New York.

This agreement includes $321 million in funding and support with $165 million from AFRL and $156 million from other sources.

These funds will be directed towards the manufacturing readiness of advanced photonics. These photonics products are critical to national security and high-performance microelectronics.

New York State Governor Kathy Hochul believes focusing R&D efforts into merging technology sectors is key to rebuilding the state’s economy. “With this funding in hand, we are now better able to ensure New York and the nation will remain at the forefront in the world of technological innovation, research and development.”

AIM Photonics, headquartered at the Albany Nanotech Complex in Upstate New York, will continue its work to develop advanced integrated photonics capabilities for a wide array of existing products and will enable critical applications such as data communications, telecommunications, LiDAR, chemical and biological sensing, artificial intelligence, quantum applications and custom DoD applications.

Are you developing new software for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Lantern Pharma Collaborates with Code Ocean

Lantern Pharma has announced a collaboration that will power their AI driven research by partnering with Code Ocean.

Lantern Pharma is an emerging, oncology-focused, clinical stage pharma at the intersection of Artificial Intelligence, Genomics, and Machine Learning. They use genomic data, computational biology modeling and AI techniques to develop therapies by clarifying the potential mechanism of action to guide development. This further helps to identify the patient groups most likely to respond toa therapy, helping to bring patients to the right treatment faster.

Code Ocean is the leading computational research environment for sharing scientific discoveries. The collaboration will allow Lantern Pharma to leverage Code Ocean’s Compute Capsule technology to expand the power of their RADR platform resulting in faster, more collaborative discoveries from the billions of RADR data points.

The key limitation faced by computational researchers today are the complexities of analyzing big data when the available tools are disparate, cumbersome, and lack security. Through this collaboration, Lantern Pharma is expected to benefit from significant efficiencies in development time and cost, as well as increased reproducibility from Code Ocean’s platform. The Code Ocean platform will offer an easy to use, collaborative research experience with an integrated development environment, secure repository, and portable Compute Capsule® technology for guaranteed reproducibility.

Are you developing new software for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Axis Research & Technologies Opens New Research and Training Facility

Axis Research & Technologies has announced the opening of their newest 10,000 sqft. facility in Nashville, Tennessee. Axis is a premiere bioskills training facility and cadaver lab space. They provide space, skill, and tools needed to support both medical research and training.

This new location will provide an expansive and fully functional operating lab for multi-skill training, private operating suites for smaller labs, large conference rooms, and configurable multi-purpose spaces. As with all Axis locations, the Nashville facility features Axis’ unique advanced HIPAA-Compliant Global Training Platform allowing surgeons, educators, and researchers to broadcast, record and tele-train anywhere around the globe.

Beyond this, the lab will be available for medical device research and development for companies and hospital groups.Axis is working on their own IP that will change the game for these companies and developers. Their goal is to create a technology that allows for more effective learning, less liability, and a more intelligent, integrative experience. Axis’s IP will change future behavior and lead to more intelligent programming in addition to collecting important data and analytics. In the near future, Axis’s new technology will include mixed medical reality and AI-powered networks to assist in live surgeries, staff training, research, and education.

Are you developing new software for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.